We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-7.64%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$563M
AUM Growth
-$101M
Cap. Flow
-$27M
Cap. Flow %
-4.8%
Top 10 Hldgs %
25.13%
Holding
123
New
15
Increased
30
Reduced
43
Closed
17

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$13.2M
2
HQY icon
HealthEquity
HQY
+$13M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.95M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$7.45M
5
ITOS
iTeos Therapeutics
ITOS
+$5.6M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.4M
2
ALHC icon
Alignment Healthcare
ALHC
+$10.3M
3
DH icon
Definitive Healthcare
DH
+$7.8M
4
TGTX icon
TG Therapeutics
TGTX
+$7.6M
5
NVTA
Invitae Corporation
NVTA
+$6.27M

Sector Composition

Rank Sector Weight
1 Healthcare 95.69%
2 Industrials 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STVN icon
101
Stevanato
STVN
$5.62B
$395K 0.07%
19,643
– –
GH icon
102
Guardant Health
GH
$21.3B
$316K 0.06%
4,770
– –
FUSN
103
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$297K 0.05%
38,198
– –
AFMD
104
DELISTED
Affimed
AFMD
$295K 0.05%
6,750
– –
RDY icon
105
Dr. Reddy's Laboratories
RDY
$10.1B
$279K 0.05%
25,020
+10,000
+67% +$113K
CRSP icon
106
CRISPR Therapeutics
CRSP
$4.88B
$205K 0.04%
3,270
– –
ALHC icon
107
Alignment Healthcare
ALHC
$3.02B
– –
-729,452
Closed -$10.3M
ALGS icon
108
Aligos Therapeutics
ALGS
$28.5M
– –
-676
Closed -$201K
BBIO icon
109
BridgeBio Pharma
BBIO
$15.7B
– –
-282,950
Closed -$4.72M
DH icon
110
Definitive Healthcare
DH
$73.9M
– –
-285,299
Closed -$7.8M
DOCS icon
111
Doximity
DOCS
$3.95B
– –
-38,750
Closed -$1.94M
LITS
112
Lite Strategy Inc
LITS
$33.4M
– –
-70,603
Closed -$3.77M
NEO icon
113
NeoGenomics
NEO
$2.04B
– –
-147,500
Closed -$5.03M
NTRA icon
114
Natera
NTRA
$38.7B
– –
-49,850
Closed -$4.66M
TDOC icon
115
Teladoc Health
TDOC
$1.21B
– –
-22,750
Closed -$2.09M
TGTX icon
116
TG Therapeutics
TGTX
$7.07B
– –
-399,949
Closed -$7.6M
VIR icon
117
Vir Biotechnology
VIR
$1.5B
– –
-6,000
Closed -$251K
KLRS
118
Kalaris Therapeutics
KLRS
$96.4M
– –
-11,350
Closed -$3.38M
OLK
119
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-170,804
Closed -$3.11M
NVTA
120
DELISTED
Invitae Corporation
NVTA
– –
-410,763
Closed -$6.27M
CELL
121
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-291,835
Closed -$5.31M
BBLN
122
DELISTED
Babylon Holdings Limited
BBLN
– –
-12,724
Closed -$1.85M
ARNA
123
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-230,043
Closed -$21.4M
1 2 3 4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sectoral Asset Management held 123 positions worth $563M, down 15% from $664M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sectoral Asset Management withdrew a net $27M in Q1 2022, closing 17 positions and reducing 43 holdings. Its most notable exit was Arena Pharmaceuticals Inc, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.

Against the trend, Sectoral Asset Management opened a new position in Biohaven Pharmaceutical Holding Company Ltd. worth $12.6M.

  • Sectoral Asset Management's largest Q1 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 105,850 shares worth $12.6M.
  • Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q1 2022, an estimated $7.95M increase.
  • Sectoral Asset Management's biggest Q1 2022 reduction was Amicus Therapeutics, cutting an estimated $5.8M.
  • Sectoral Asset Management fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $21.4M.
  • Sectoral Asset Management's ten largest holdings make up 25% of its $563M portfolio in Q1 2022.
  • Sectoral Asset Management opened 15 new positions and closed 17 in Q1 2022.
  • Sectoral Asset Management's portfolio value fell 15% quarter-over-quarter to $563M.

Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.